Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUND, ANTI-ALLERGY DRUG, AND MEDIATOR RELEASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2019/225035
Kind Code:
A1
Abstract:
The compound represented by the general formula exhibits strong anti-allergy activity. R1 represents a substituted or unsubstituted acyloxy group, or a substituted or unsubstituted acylamino group. R2 represents a substituted or unsubstituted alkyl group.

Inventors:
TAI AKIHIRO (JP)
MIURA KAORI (JP)
WAKAYAMA SACHIO (JP)
Application Number:
PCT/JP2018/044160
Publication Date:
November 28, 2019
Filing Date:
November 30, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LAIMU CORP (JP)
International Classes:
C07D307/62; A61K31/366; A61P37/08
Domestic Patent References:
WO2014050894A12014-04-03
WO2009014343A22009-01-29
Foreign References:
JP2017031083A2017-02-09
JP2015003894A2015-01-08
JPS61263969A1986-11-21
JP2019006692A2019-01-17
Other References:
IWAOKA, Y. ET AL.: "Affinity resins as new tools for identifying target proteins of ascorbic acid", ANALYST, vol. 143, no. 4, 9 January 2018 (2018-01-09), pages 874 - 882, XP055655485
KATO, K. ET AL.: "Studies on Scavengers of Active Oxygen Species. 1.Synthesis and Biological Activity of 2-0-Alkylascorbic Acids", J. MED. CHEM., vol. 31, no. 4, 1988, pages 793 - 798, XP055655494
TAI, AKIHIRO ET AL.: "Antiallergic Effects of Ascorbic Acid Derivatives", VI TAMINS, vol. 91, no. 9, 2017, pages 579 - 580
Attorney, Agent or Firm:
SIKS & CO. (JP)
Download PDF: